These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25650905)

  • 21. Defective ryanodine receptor interdomain interactions may contribute to intracellular Ca2+ leak: a novel therapeutic target in heart failure.
    Lehnart SE; Wehrens XH; Marks AR
    Circulation; 2005 Jun; 111(25):3342-6. PubMed ID: 15983258
    [No Abstract]   [Full Text] [Related]  

  • 22. Ryanodine receptor structure: progress and challenges.
    Hamilton SL; Serysheva II
    J Biol Chem; 2009 Feb; 284(7):4047-51. PubMed ID: 18927076
    [No Abstract]   [Full Text] [Related]  

  • 23. Structural characterization of the RyR1-FKBP12 interaction.
    Samsó M; Shen X; Allen PD
    J Mol Biol; 2006 Mar; 356(4):917-27. PubMed ID: 16405911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance.
    Gao L; Balshaw D; Xu L; Tripathy A; Xin C; Meissner G
    Biophys J; 2000 Aug; 79(2):828-40. PubMed ID: 10920015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structural biology of ryanodine receptors.
    Kimlicka L; Van Petegem F
    Sci China Life Sci; 2011 Aug; 54(8):712-24. PubMed ID: 21786194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural insights into endoplasmic reticulum stored calcium regulation by inositol 1,4,5-trisphosphate and ryanodine receptors.
    Seo MD; Enomoto M; Ishiyama N; Stathopulos PB; Ikura M
    Biochim Biophys Acta; 2015 Sep; 1853(9):1980-91. PubMed ID: 25461839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FRET-based trilateration of probes bound within functional ryanodine receptors.
    Svensson B; Oda T; Nitu FR; Yang Y; Cornea I; Chen-Izu Y; Fessenden JD; Bers DM; Thomas DD; Cornea RL
    Biophys J; 2014 Nov; 107(9):2037-48. PubMed ID: 25418089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bend to open?
    Minor DL
    Structure; 2005 Aug; 13(8):1094-5. PubMed ID: 16084381
    [No Abstract]   [Full Text] [Related]  

  • 29. Cryo-EM and single particles.
    Wang L; Sigworth FJ
    Physiology (Bethesda); 2006 Feb; 21():13-8. PubMed ID: 16443818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.
    Amador FJ; Kimlicka L; Stathopulos PB; Gasmi-Seabrook GM; Maclennan DH; Van Petegem F; Ikura M
    J Mol Biol; 2013 Nov; 425(21):4034-46. PubMed ID: 23978697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional reconstruction of the recombinant type 3 ryanodine receptor and localization of its amino terminus.
    Liu Z; Zhang J; Sharma MR; Li P; Chen SR; Wagenknecht T
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6104-9. PubMed ID: 11353864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor.
    Yamamoto T; Ikemoto N
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1102-8. PubMed ID: 11866478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping domains and mutations on the skeletal muscle ryanodine receptor channel.
    Hwang JH; Zorzato F; Clarke NF; Treves S
    Trends Mol Med; 2012 Nov; 18(11):644-57. PubMed ID: 23069638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing the role of negatively charged amino acid residues in ion permeation of skeletal muscle ryanodine receptor.
    Wang Y; Xu L; Pasek DA; Gillespie D; Meissner G
    Biophys J; 2005 Jul; 89(1):256-65. PubMed ID: 15863483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS.
    Kauferstein S; Kiehne N; Erkapic D; Schmidt J; Hamm CW; Bratzke H; Pitschner HF; Kuniss M; Neumann T
    Int J Cardiol; 2011 Jan; 146(2):249-50. PubMed ID: 21126784
    [No Abstract]   [Full Text] [Related]  

  • 36. The cardiac ryanodine receptor N-terminal region contains an anion binding site that is targeted by disease mutations.
    Kimlicka L; Tung CC; Carlsson AC; Lobo PA; Yuchi Z; Van Petegem F
    Structure; 2013 Aug; 21(8):1440-9. PubMed ID: 23871484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural determinants for activation or inhibition of ryanodine receptors by basic residues in the dihydropyridine receptor II-III loop.
    Casarotto MG; Green D; Pace SM; Curtis SM; Dulhunty AF
    Biophys J; 2001 Jun; 80(6):2715-26. PubMed ID: 11371447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an alpha-helical ryanodine receptor C-terminal tail peptide on ryanodine receptor activity: modulation by Homer.
    Pouliquin P; Pace SM; Curtis SM; Harvey PJ; Gallant EM; Zorzato F; Casarotto MG; Dulhunty AF
    Int J Biochem Cell Biol; 2006; 38(10):1700-15. PubMed ID: 16725367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.
    Karunasekara Y; Rebbeck RT; Weaver LM; Board PG; Dulhunty AF; Casarotto MG
    FASEB J; 2012 Dec; 26(12):5049-59. PubMed ID: 22962299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ryanodine receptor calcium release channels: lessons from structure-function studies.
    Amador FJ; Stathopulos PB; Enomoto M; Ikura M
    FEBS J; 2013 Nov; 280(21):5456-70. PubMed ID: 23413940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.